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Abstract We have exploited reconstitution in the fission yeast
Schizosaccharomyces pombe to investigate how activation of
phospholipase CQ (PLCQ) by the platelet-derived growth factor-L
receptor (PDGFLR) is regulated by the SH2 domain-containing
protein tyrosine phosphatase PTP2C (also known as SHP-2).
When co-expressed in S. pombe, PTP2C abolished PDGFLR
autophosphorylation as well as its ability to phosphorylate and
activate PLCQ. Inhibition of PDGFLR signalling by PTP2C
appears specific insofar that PTP1C, a close homologue of
PTP2C, does not suppress activation of either PDGFLR or
PLCQ. Surprisingly, an inactive PTP2C mutant (C459S), which
dephosphorylates neither PDGFLR nor PLCQ, remains fully
effective as an inhibitor of [3H]inositol phosphate generation
indicating that negative regulation is at least in part independent
of catalytic activity. This contrasts with PLCQ activation by c-
Src which, although blocked by active PTP2C, is not inhibited by
the mutant PTP2C C459S. These observations indicate that in
addition to a reported positive role relaying trophic signals,
PTP2C can also exert a negative effect on the PDGFLR and its
signalling to PLCQ.
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1. Introduction
To mediate changes in cellular growth and di¡erentiation,
many trophic factors activate cell surface receptors by pro-
moting subunit dimerisation and autophosphorylation at in-
tracellular tyrosine residues. These provide high-a⁄nity bind-
ing sites for src homology 2 (SH2) and the phosphotyrosine
binding (PTB) domains within a set of signalling proteins
which include the regulatory subunit of phosphatidylinositol
3P-kinase (p85 of PI3K), phospholipase CQ (PLCQ), the
GTPase-activating protein (GAP) of p21ras, Src family tyro-
sine kinases, as well as adapter proteins such as SHC and the
p21ras-activating complex GRB2/SOS. These e¡ector targets
are then tyrosine phosphorylated and/or enzymatically acti-
vated leading to changes in cellular phosphorylation state
and production of a range of second messenger molecules
which together elicit an appropriate biological response [1^
3]. Despite considerable progress in our mechanistic under-
standing of these events, one major outstanding question is
how signalling from the receptor is terminated. Since tyrosine
phosphorylation plays a central role in signal propagation it is
however likely that protein tyrosine phosphatases (PTPs) play
a key role in the process of down-regulation.
Over 75 PTPs have so far been identi¢ed and these can be
categorised structurally into transmembrane and intracellular
molecular species [4,5]. One class of intracellular PTPs pos-
sesses tandem SH2 domains within their N-terminus and ap-
pears to play a key role regulating signal transduction by cell
surface receptors [6]. PTP1C (also known as SHP-1, HCP,
SH-PTP1, SHP) for instance, is expressed predominantly in
hematopoietic cells and suppresses responsiveness to IL3, steel
factor, erythropoietin as well as mediating inhibition of sev-
eral immunological signalling systems [6^12]. This is consis-
tent with genetic evidence from two mouse mutants, motheat-
en and viable motheaten, where mutations within PTP1C result
in excessive erythropoiesis and severe immune disregulation
[13,14]. PTP2C (also known as SHP-2, Syp, PTP1D and
SH-PTP2) is a second member of the SH2 domain subfamily
and is expressed widely in many tissues [15^20]. PTP2C inter-
acts with activated PDGF, EGF, HER2-neu and c-kit recep-
tors as well as with insulin receptor substrate-1 [19^24]
although surprisingly, this PTP appears to play a positive
role mediating mitogenic signalling [25^27]. This also appears
consistent with genetic analysis of the closely related drosophi-
la gene corkscrew which acts upstream of Raf to transduce
essential signals from the receptor tyrosine kinase torso during
embryonic development [28,29]. What remains less clear from
these studies however, are the targets of PTP2C catalytic ac-
tivity and whether dephosphorylation of tyrosine residues
could play a negative regulatory role in receptor-linked signal-
ling.
We have reported recently use of the ¢ssion yeast Schizo-
saccharomyces pombe to reconstitute PDGFL receptor
(PDGFLR)- and c-Src-mediated phosphorylation and enzy-
matic activation of PLCQ [30]. In studies reported here we
extend these ¢ndings to assess the role of PTP2C in this path-
way.
2. Materials and methods
2.1. Strains, media and plasmid constructs
The host strain for S. pombe transformation, and the procedure for
protoplast transformation were as described [30]. The bacterial strain
for routine work was JM101TR (supE, thi3, srl: :tn10, recA v(lac-
proAB), [FP, traD36, proAB, lacIZvM15]) and standard media were
used throughout. As described previously [30,31], cDNAs encoding
rat PLCQ2 cDNA, wild-type and K602A point mutated mouse PDGFL
receptor, as well as human c-Src were subcloned into the thiamine-
repressible S. pombe expression vectors pREP3, pREP4 and pREP7,
respectively. In the appropriate host strain Sp31 (h leu1-32 ura4-D18
ade6-704 his5-303) these vectors allow independent selection in media
lacking leucine (pREP3), uracil (pREP4) or histidine (pREP7). Hu-
man Csk and where indicated Src cDNAs were expressed from the
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S. pombe adh promoter by subcloning into plasmids allowing selection
in medium lacking leucine (pART1-leu), uracil (pART1-ura) or ad-
enine (pART1-ade). PTP2C and PTP1C cDNAs were kindly provided
by Dr. S.-H. Shen (Biotechnology Research Institute, Montreal, Que-
bec, Canada) and the coding sequences isolated as BamH1-AccI and
ClaI-NruI fragments, respectively, and subcloned into the ade6 vec-
tor pREP5. The catalytically inactive PTP2C point mutation C459S
was constructed following using the mutagenic oligonucleotide
CCAATTCCAGCACTAGAGTGCACCACGACC.
2.2. Yeast culture and sample handling
The growth, harvesting and homogenisation of yeast cells, as well
as the labelling of yeast phosphoinositides using [3H]inositol and sub-
sequent isolation of [3H]inositol phosphates, were all performed ex-
actly as we reported previously [30]. Western analysis was also exactly
as described [30] using antibodies from the following sources: c-Src
(N16; Santa Cruz Biotechnology, Inc., Basel, Switzerland), Csk
(Transduction laboratories, Nottingham, UK), PTP2C (C-18; Santa
Cruz Biotechnology, Inc., Basel, Switzerland), PTP1C (#P17320;
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Fig. 1. PTP2C blocks tyrosine phosphorylation of the PDGFLR and PLCQ upon co-expression in S. pombe. Co-expression of PDGFLR,
PLCQ2 and PTP2C or PTP1C in the ¢ssion yeast S. pombe. Western blot analysis was performed using crude homogenates prepared from yeast
cells grown under inducing conditions for 18 h and expressing the mouse PDGFLR and rat PLCQ2 either alone (box/lane 1) or together with
human PTP2C (box/lane 2), the inactive mutant PTP2C C459S (box/lane 3), or human PTP1C (box/lane 4). Samples were analysed using anti-
body speci¢c for either phosphotyrosine, the PDGFLR, PLCQ2, PTP2C or PTP1C as indicated. The positions of immunoreactive proteins are
indicated by arrows whereas bands corresponding to tyrosine phosphorylated PDGFLR, PLCQ and PTP2C are labelled where these are detect-
able. Phosphotyrosine boxes 1^4 represent the same exposure of the same Western blot with identical protein loading and are directly compara-
ble. All antibodies failed to reveal immunoreactive bands in untransformed cells (see also [30]).
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Transduction Laboratories, Nottingham, UK), PLCQ2 (C-19; Santa
Cruz Biotechnology, Inc., Basel, Switzerland) and phosphotyrosine
(4G10; Upstate Biotechnology, Inc., Lake Placid, USA). Antibodies
speci¢c for the mouse PDGFL receptor and a second antibody recog-
nising PLCQ2 were kindly supplied by Professor L.T. Williams (Uni-
versity of California, San Francisco, CA) and Professor Y. Homma
(Fukushima Medical College, Japan), respectively. Antibody binding
was detected using horseradish peroxide (HRP)-conjugated second
antibody (Bio-Rad laboratories, Glattbrugg, Switzerland) or protein
A/G-HRP (Pierce, Zurich, Switzerland) and ECL detection (Amer-
sham, Zurich, Switzerland).
2.3. PTP2C and PLCQ2 immunoprecipitation
Crude homogenates were prepared and 200 Wl aliquots mixed with
800 Wl of ice-cold bu¡er L (1% NP40, 20 mM Tris-HCl, 150 mM
NaCl, 50 mM NaF, 1 mM Na3VO4, 10 mM sodium pyrophosphate,
1 mM EDTA, 5 mM benzamidine, 10 Wg/ml aprotonin, 10 Wg/ml of
leupeptin, 10 Wg/ml of chymostatin and 1.0 mM PMSF at pH 7.5)
followed by incubation on ice for 1 h. For immunoprecipitation sam-
ples were centrifuged at 100 000Ug for 30 min and 800 Wl of cleared
lysate incubated with 20 Wl of PTP2C or 10 Wl of PLCQ2 speci¢c
antibody (as above) overnight at 4‡C with mixing after which time
100 Wl of a 1:1 (v/v) mix of protein A Sepharose and protein G
Sepharose (50% w/v; Pharmacia Biotech., Uppsala, Sweden) was
added and incubated for a further 2 h on ice with mixing. Beads
were then sedimented by centrifugation and washed three times in
1.0 ml of bu¡er L followed by resuspension in 100 Wl of SDS-
PAGE sample bu¡er and heating at 95‡C for 5 min.
3. Results
3.1. PTP2C dephosphorylates the PDGFLR and PLCQ
We have reported previously that mammalian PLCQ2 co-
expressed with the PDGFLR in S. pombe becomes tyrosine
phosphorylated and enzymatically activated to generate
[3H]inositol phosphates from prelabelled endogenous yeast
membrane phosphoinositides [30]. It is of note that upon ex-
pression in S. pombe the PDGFLR appears to be constitu-
tively active and insensitive to further stimulation with
PDGF [30]. Using this system we have now investigated the
regulatory actions of the human SH2 domain-containing pro-
tein tyrosine phosphatase PTP2C. When expressed in S.
pombe PTP2C is immunodetectable as a protein of 68 kda
and has no apparent e¡ect on the levels of co-expressed
PDGFLR or PLCQ2 (Fig. 1). The presence of PTP2C does
however, abolish completely PDGFLR-dependent autophos-
phorylation as well as tyrosine phosphorylation of PLCQ2
(Fig. 1). Under these conditions the only protein undergoing
extensive tyrosine phosphorylation in these cells is PTP2C
itself. Immunoprecipitation experiments con¢rm the molecu-
lar identity of PTP2C as the major phosphoprotein under
these conditions (Fig. 2) and is consistent with growth fac-
tor-dependent tyrosine phosphorylation of PTP2C reported
previously in mammalian cells [19^22]. Dephosphorylation
of the PDGFLR by PTP2C re£ects tight interaction between
these components as indicated by strong co-immunoprecipita-
tion (Fig. 2). This contrasts with PLCQ2 which is not detect-
ably precipitated using PTP2C antibody (not shown).
3.2. PTP2C blocks PDGFLR-dependent PLCQ activation
To assess the functional consequences of suppressing
PDGFLR and PLCQ2 tyrosine phosphorylation, we measured
generation of [3H]inositol phosphates from prelabelled yeast
cells [30]. Consistent with a critical role for tyrosine phospho-
rylation in this signalling pathway, PTP2C co-expression in-
hibits the generation of [3H]inositol phosphates to near basal
levels as observed when PLCQ2 is co-expressed with the inac-
tive PDGFLR mutant, K602A (Fig. 3). To test the impor-
tance of PTP2C catalytic activity in the inhibition of
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Fig. 2. PDGFLR co-immunoprecipitates with PTP2C from S. pombe. Lysates from yeast cells co-expressing the PDGFLR and PLCQ2 either
alone or together with PTP2C or mutant inactive PTP2C C459S were subjected to immunoprecipitation using an antibody against PTP2C and
protein A/G-Sepharose. Samples were analysed by Western blotting with antibodies speci¢c for PTP2C, phosphotyrosine or PDGFLR as indi-
cated. The positions of PDGFLR and PTP2C are indicated by arrows. Note that the PDGFLR is dephosphorylated only when coprecipitated
with active PTP2C.
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PDGFLR and PLCQ2 activation state we constructed the cat-
alytically inactive point mutant C459S. As expected, this mu-
tant is unable to dephosphorylate either PDGFLR or PLCQ2
(Fig. 1). Surprisingly however, PTP2C C459S remains fully
e¡ective as an inhibitor of PLCQ2 enzymatic activation (Fig.
3). As with wild-type PTP2C, the C459S mutant readily co-
immunoprecipitates with the PDGFL (Fig. 2). Together, these
observations demonstrate that PTP2C is able to block
PDGFLR-linked signalling to PLCQ2 but that this inhibition
does not necessarily depend on tyrosine dephosphorylation.
3.3. PTP2C blocks PLCQ phosphorylation and activation by
c-Src
To investigate further the negative regulatory role of
PTP2C, we next analysed its in£uence on the ability of c-
Src to stimulate PLCQ2 tyrosine phosphorylation and enzy-
matic activation [30]. For this study we constructed a yeast
strain in which c-Src, Csk, PLCQ2 and PTP2C are all ex-
pressed in the same cell. The presence of each of these pro-
teins was con¢rmed by Western blotting (Fig. 4). The distri-
bution of phosphotyrosine-containing proteins (Fig. 4) shows
that, in contrast to the results obtained with PDGFLR, c-Src
or Csk enzymatic activity does not result in detectable tyro-
sine phosphorylation of PTP2C, nor does PTP2C alter the net
level of c-Src tyrosine phosphorylation or indeed, c-Src enzy-
matic activity (not shown). Despite this, PTP2C is active in
reversing the Src-induced tyrosine phosphorylation of PLCQ2,
and as shown in Fig. 5, also abolishes hydrolysis of endoge-
nous S. pombe [3H]inositol-containing phospholipids. As ex-
pected, co-expression of the catalytically inactivated mutant
PTP2C C459S is unable to prevent c-Src-dependent PLCQ2
tyrosine phosphorylation (Fig. 4). Interestingly, PTP2C
C459S is tyrosine phosphorylated suggesting that Src and/or
Csk can actually modify PTP2C but that when catalytically
active this PTP is able to autodephosphorylate (Fig. 4). As
anticipated, although in contrast to our observations with
PDGFLR described above, catalytically inactive PTP2C
C459S does not inhibit the ability of PLCQ2 to generate
[3H]inositol phosphates (Fig. 5) from prelabelled S. pombe
membranes.
3.4. PTP1C is unable to dephosphorylate PDGFLR or its
signalling to PLCQ
As a measure of speci¢city of PTP2C action, we assessed
the regulatory actions of the PTP2C homologue PTP1C which
is immunodetectable in yeast extracts as a doublet at 68 kda
and 66 kDa (Figs. 1 and 4). In mammalian cells PTP1C runs
as a protein of V68 kda and we assume that the smaller of
the two bands detected in yeast is a consequence of N-termi-
nal degradation as the monoclonal antibody used for Western
analysis recognises a peptide from the PTP1C C-terminal. In
contrast to observations with PTP2C, when PTP1C was co-
expressed together with PDGFLR and PLCQ2, there is no
detectable decrease in tyrosine phosphorylation of either com-
ponent (Fig. 1). Also unlike PTP2C, PTP1C is not detectably
tyrosine phosphorylated by the PDGFLR (Fig. 1). Consistent
with PTP1C inactivity against PDGFLR-dependent tyrosine
phosphorylation, PTP1C was totally ine¡ective as an inhibitor
of yeast phosphoinositide hydrolysis by activated PLCQ2 (data
not shown). This does not re£ect synthesis of inactive enzyme
in S. pombe as PTP1C co-expression with c-Src substantially
reduces both tyrosine phosphorylation (Fig. 4) and activation
of PLCQ2 (not shown). Furthermore, as observed with
PTP2C, PTP1C enzymatic activity is also evident by the com-
plete reversal of Src-dependent tyrosine phosphorylation of
multiple endogenous yeast proteins (Fig. 4).
4. Discussion
Fission yeast provides a convenient host in which to recon-
stitute interactions between mammalian signalling molecules
[30,32^35]. Furthermore, since tyrosine phosphorylation ap-
pears not to be a feature of signal transmission in yeast and
proteins containing the SH2 motif responsible for binding
phosphotyrosine have not been identi¢ed, investigation of
the mechanisms underlying tyrosine kinase-linked signalling
is free from interfering endogenous yeast proteins. We have
described previously activation of PLCQ in ¢ssion yeast in
response to phosphorylation by both receptor (PDGFLR)
and non-receptor (c-Src) tyrosine kinases [30] and in the
present report we extend our ¢ndings to include the regulatory
actions of the SH2-containing phosphatase PTP2C. Although
most of the evidence to date indicates a positive signalling role
for PTP2C (see Section 1), speci¢c targets for PTP2C catalytic
activity in vivo have not been identi¢ed and the question of
whether tyrosine dephosphorylation by PTP2C plays a regu-
latory role in signalling remains unresolved. This is the ques-
tion we have begun to address using the ¢ssion yeast. The
principal conclusions of the present study are: (i) PTP2C
acts selectively to dephosphorylate the PDGFLR but not c-
Src; (ii) PTP2C dephosphorylates PLCQ modi¢ed by the
PDGFLR and c-Src and blocks hydrolysis of endogenous in-
ositol-containing phospholipids; (iii) the catalytically inactive
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Fig. 3. PTP2C and inactive mutant PTP2C C459S block PLCQ2 en-
zymatic activation by PDGFLR. S. pombe expressing the PDGFLR
and PLCQ2 either alone or together with PTP2C or the inactive mu-
tant PTP2C C459S (as indicated) were grown under inducing condi-
tions in the presence of [3H]inositol for 18 h. Cells were extracted
with CHCl3-CH3OH-HCl and [3H]inositol phosphates isolated by
anion-exchange chromatography. Radioactivity eluting as [3H]IP1,
[3H]IP2 and [3H]IP3 is shown as disintegrations per minute (dpm)
and is derived from a 6 ml yeast cell culture. PDGFLR catalytically
inactivated by point mutation (K602A) fails to co-express PLCQ2 ty-
rosine phosphorylation in ¢ssion yeast [30] and demonstrates back-
ground production of [3H]inositol phosphates. Bars represent the
means of duplicate determinations and data are representatives of
four separate experiments.
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mutant PTP2C C459S also inhibits PLCQ activation by
PDGFLR but not by c-Src; and (iv) PTP1C does not regulate
PDGFLR signalling revealing distinct substrate preferences
for these two enzymes within the intracellular environment
of ¢ssion yeast.
It is of note that although experiments in mammalian cells
have indicated a positive signalling role for PTP2C [25^27],
our observations in S. pombe are in agreement with recent
reports showing that puri¢ed PTP2C dephosphorylates
PDGFLR immunoprecipitated from activated mammalian
cells [36] and that it displays substrate speci¢city for phospho-
peptides corresponding to the C-terminal of the PDGFLR
[37,38]. Negative control of the PDGFLR is also consistent
with the slowed dephosphorylation of a point mutated
PDGFLR (Y1009F) unable to interact with PTP2C following
cellular stimulation [36]. Signi¢cantly, recent experiments us-
ing ¢broblasts derived from mice homozygous for a targeted
mutation in PTP2C also reveal negative regulatory control of
PDGFLR tyrosine phosphorylation as well as its downstream
signalling to MAP kinase activation [39]. Together, these ob-
servations indicate that in addition to mediating positive sig-
nals underlying trophic responses in some cells, PTP2C can
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Fig. 4. PTP2C inhibits PLCQ tyrosine phosphorylation by c-Src. Co-expression of c-Src, Csk, PLCQ2 and PTP2C or PTP1C in S. pombe. West-
ern blot analysis was performed using crude homogenates prepared from yeast cells grown under inducing conditions for 18 h and expressing
human c-Src, human Csk and rat PLCQ2 either alone (box/lane 1) or together with human PTP2C (box/lane 2), inactive mutant PTP2C C459S
(box/lane 3), or human PTP1C (box/lane 4). Extracts were probed using antibodies speci¢c for either phosphotyrosine, Src, Csk, PLCQ, PTP2C
or PTP1C. The positions of immunoreactive proteins are indicated by arrow heads whereas bands corresponding to tyrosine phosphorylated
PLCQ, Src and mutant inactive PTP2C are labelled where these are detectable. Phosphotyrosine boxes 1^4 represent the same exposure of the
same Western blot with identical protein loading and are directly comparable. All antibodies failed to reveal immunoreactive bands in untrans-
formed cells (see also [30]).
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also mediate feedback inhibition of receptor tyrosine kinase
activation and suppress coupling to a subset of e¡ector tar-
gets.
One surprising result emerging from our studies was that a
catalytically inactive PTP2C point mutant (C459S) was fully
e¡ective at inhibiting PDGFLR-dependent activation of oth-
erwise highly phosphorylated PLCQ2. This contrasts with
PTP2C C459S inactivity against PLCQ2 tyrosine phosphoryl-
ated and activated by c-Src suggesting an action at the level of
the PDGFLR. Consistent with this, the PDGFLR but not
PLCQ2 co-immunoprecipitated with PTP2C C459S. One po-
tential mechanism accounting for blockade of inositol phos-
phate generation is a competitive inhibition by PTP2C C459S
of productive interaction of PLCQ2 with the PDGFLR. This
may be expected as SH2 domains within PTP2C and PLCQ
appear to bind adjacent and potentially overlapping phospho-
tyrosine residues (Tyr1009, Tyr1021) within the C-terminal of
the PDGFLR [21,40^43]. Consistent with this model, EGF
receptor mutations lacking C-terminal residues crucial for
PLCQ interaction fail to mediate enzymatic activation of
PLCQ despite its extensive tyrosine phosphorylation [44,45].
Moreover, binding of GAP and the p85 subunit of PI3K to
the PDGFLR were shown recently to silence signalling to
PLCQ activation [46]. Coincident interactions between the
PDGFLR and a subset of e¡ector targets including GAP,
PI3K and PTP2C may therefore block e¡ective receptor in-
teraction with PLCQ and thus inhibit its enzymatic activation.
In summary, although PTP2C and its drosophila homologue
corkscrew appear to play a role mediating positive trophic
signals, our observations in S. pombe indicate that PTP2C
may also have a negative regulatory action inhibiting the ac-
tivated state of the PDGFLR itself as well as suppressing
coupling to a subset of downstream e¡ector targets.
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change chromatography. Radioactivity eluting as [3H]IP1, [3H]IP2
and [3H]IP3 is shown as disintegrations per minute (dpm) and is de-
rived from a 6 ml yeast cell culture. PDGFLR catalytically inacti-
vated by point mutation (K602A) and co-expressed with PLCQ2 is
shown to demonstrate background [3H]inositol phosphate genera-
tion. Bars represent the means of duplicate determinations and data
are representatives of four separate experiments.
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